irsogladine has been researched along with Lung Neoplasms in 2 studies
irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Irsogladine failed to inhibit proliferation, tubular formation, and the uPA/MMP-1 mRNA expression of HUVEC cells." | 5.32 | Inhibition of breast cancer regrowth and pulmonary metastasis in nude mice by anti-gastric ulcer agent, irsogladine. ( Maeda, M; Nozaki, S; Sledge, GW; Tsuda, H, 2004) |
| "Irsogladine maleate (IM) is a drug invented to treat gastric ulcers; however, several reports have shown that IM also exerts anti-angiogenetic effects in vitro, in vivo and in humans." | 2.78 | A randomized phase III trial of postoperative adjuvant therapy for completely resected stage IA-IIIA lung cancer using an anti‑angiogenetic agent: irsogladine maleate. ( Abiko, M; Deguchi, H; Endo, C; Hasumi, T; Kondo, T; Matsumura, Y; Nakamura, Y; Sagawa, M; Sakuma, T; Sato, N; Shibuya, J; Suzuki, H; Takahashi, S, 2013) |
| "Irsogladine failed to inhibit proliferation, tubular formation, and the uPA/MMP-1 mRNA expression of HUVEC cells." | 1.32 | Inhibition of breast cancer regrowth and pulmonary metastasis in nude mice by anti-gastric ulcer agent, irsogladine. ( Maeda, M; Nozaki, S; Sledge, GW; Tsuda, H, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sagawa, M | 1 |
| Shibuya, J | 1 |
| Takahashi, S | 1 |
| Endo, C | 1 |
| Abiko, M | 1 |
| Suzuki, H | 1 |
| Matsumura, Y | 1 |
| Sakuma, T | 1 |
| Sato, N | 1 |
| Deguchi, H | 1 |
| Nakamura, Y | 1 |
| Hasumi, T | 1 |
| Kondo, T | 1 |
| Nozaki, S | 1 |
| Maeda, M | 1 |
| Tsuda, H | 1 |
| Sledge, GW | 1 |
1 trial available for irsogladine and Lung Neoplasms
| Article | Year |
|---|---|
A randomized phase III trial of postoperative adjuvant therapy for completely resected stage IA-IIIA lung cancer using an anti‑angiogenetic agent: irsogladine maleate.
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Ther | 2013 |
1 other study available for irsogladine and Lung Neoplasms
| Article | Year |
|---|---|
Inhibition of breast cancer regrowth and pulmonary metastasis in nude mice by anti-gastric ulcer agent, irsogladine.
Topics: Animals; Anticarcinogenic Agents; Breast Neoplasms; Female; Humans; Lung Neoplasms; Mice; Mice, Nude | 2004 |